Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Freedom Bunker
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Tesla Earnings Preview: “Braced For A Miss”

% of readers think this story is Fact. Add your two cents.


Tesla Earnings Preview: “Braced For A Miss”

Tesla reports after the US market close on Wednesday and according to the UBS trading desk, there has been very little discussion around TSLA lately, with the stock drifting 14% lower for most of the year until last week, when it squeezed higher to trade just below $390. 

The company has been the laggard among mega-cap peers despite still-lofty expectations. Consensus points to 1Q revenue of about $22.7 billion, with adjusted EPS around 38 cents and roughly 25 cents on a reported basis, even as deliveries of about 358,000 vehicles missed forecasts and flagged softer core auto demand. Analysts still expect a sharp rebound, with roughly 30% profit growth and a 15% increase in revenue.

Markets will likely overlook near-term weakness but focus heavily on what’s next: Investors are looking for updates on the robotaxi rollout, AI and robotics, as well as clarity on cash burn tied to a planned step-up in capex to as much as $20 billion this year. The disconnect is stark: as Bloomberg notes, a cyclical slowdown in autos versus an equity story still priced on long-duration growth, reflected in valuation metrics that are stretched across the board (roughly 184x forward earnings, ~15x sales and over 100x EV/EBITDA).

Taking a step back, the good news for Tesla – and the broader market – is that earnings revisions for the S&P 500 continue to trend higher for 2026 and 2027, even if largely concentrated in a handful of AI stocks – and early results have been solid, with a strong beat rate. But the reaction function is fading. According to Bank of America, stocks are no longer rewarding top and bottom line beats as they typically do, suggesting a high bar for earnings driven gains as the index hovers near all-time highs. 

Tesla, as one of the highest-duration names in the market, becomes a key test of that dynamic. If management reinforces the AI/autonomy narrative and justifies elevated capex, it supports the broader recovery in tech. But the overhang remains what is going on with Iran and the state of peace talks. This is not a market driven by idiosyncratic earnings. Netflix’s 10% drop alongside rising indexes underscores that geopolitics are taking precedence.

UBS analyst Joe Spak upgraded TSLA from Sell to Neutral last week as the stock reached his price target, and now sees a more balanced risk/reward profile – near‑term demand challenges and an investment phase offset by a longer‑term physical AI opportunity.

For 1Q, Spak expects an EPS miss, which is unlikely to be a surprise. UBS is modeling adjusted EPS of $0.33 versus $0.44 consensus. However, Spak believes the buy side is already braced for a miss based on 1Q26 delivery data, particularly weaker energy storage deployments.

Spak is modeling auto gross margins (ex‑credits) of 16.1% versus 15.5% consensus, believing FSD could help keep margins slightly elevated. If Tesla books an IEPPA receivable this quarter, that could further support gross margins and provide upside to expectations. Otherwise, Spak expects updates on Tesla’s long‑term vision, primarily focused on Robotaxi, Optimus, FSD, and the TeraFab.

Key areas where UBS expects additional detail include:

  1. Color on demand trends across all regions
  2. Reasons behind the energy storage deployment miss and implications for the balance of the year
  3. Updates on Robotaxi deployment across additional cities
  4. Progress on Gen 3 Optimus
  5. Capex outlook not only for 2026 but beyond, including funding plans (TeraFab, solar, etc.)
  6. Progress on the six factories TSLA plans to build this year
  7. Commentary on commodity and logistics costs

Tune in shortly after the close for the full results.

Tyler Durden Wed, 04/22/2026 – 15:34


Source: https://freedombunker.com/2026/04/22/tesla-earnings-preview-braced-for-a-miss/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login